- Home
- DRCT vs PAVM Comparison
DRCT vs PAVM Comparison
Compare DRCT & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- PAVM
- Stock Information
- Founded
- DRCT 2018
- PAVM 2014
- Country
- DRCT United States
- PAVM United States
- Employees
- DRCT N/A
- PAVM N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- PAVM Medical/Dental Instruments
- Sector
- DRCT Technology
- PAVM Health Care
- Exchange
- DRCT Nasdaq
- PAVM Nasdaq
- Market Cap
- DRCT 8.8M
- PAVM 9.4M
- IPO Year
- DRCT 2022
- PAVM 2016
- Fundamental
- Price
- DRCT $0.35
- PAVM $0.43
- Analyst Decision
- DRCT Strong Buy
- PAVM Strong Buy
- Analyst Count
- DRCT 1
- PAVM 1
- Target Price
- DRCT $6.00
- PAVM $20.00
- AVG Volume (30 Days)
- DRCT 5.5M
- PAVM 738.1K
- Earning Date
- DRCT 11-07-2025
- PAVM 11-12-2025
- Dividend Yield
- DRCT N/A
- PAVM N/A
- EPS Growth
- DRCT N/A
- PAVM N/A
- EPS
- DRCT N/A
- PAVM 0.83
- Revenue
- DRCT $36,459,000.00
- PAVM $1,020,000.00
- Revenue This Year
- DRCT $16.81
- PAVM N/A
- Revenue Next Year
- DRCT $35.28
- PAVM $234.47
- P/E Ratio
- DRCT N/A
- PAVM $0.52
- Revenue Growth
- DRCT N/A
- PAVM N/A
- 52 Week Low
- DRCT $0.28
- PAVM $0.30
- 52 Week High
- DRCT $6.59
- PAVM $1.25
- Technical
- Relative Strength Index (RSI)
- DRCT 48.96
- PAVM 44.31
- Support Level
- DRCT $0.33
- PAVM $0.40
- Resistance Level
- DRCT $0.37
- PAVM $0.48
- Average True Range (ATR)
- DRCT 0.05
- PAVM 0.06
- MACD
- DRCT 0.00
- PAVM -0.01
- Stochastic Oscillator
- DRCT 26.61
- PAVM 19.15
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.